730. Cefiderocol for the Treatment of Achromobacter xylosoxidans Infections in Two Lung Transplant Patients with Cystic Fibrosis

BACKGROUND: Achromobacter xylosoxidansis a highly resistant Gram-negative bacterium that causes chronic infections in patients with cystic fibrosis (CF). Treatment options for A. xylosoxidans are limited. In the peri-lung transplant setting, the treatment of A. xylosoxidans infections is especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Warner, Nathaniel C, Bartelt, Luther, Lachiewicz, Anne, Tompkins, Kathleen Marie, Miller, Melissa B, van Duin, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810970/
http://dx.doi.org/10.1093/ofid/ofz360.798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810970/
http://dx.doi.org/10.1093/ofid/ofz360.798

Ejemplares similares